LUV
59
-3
XYL
39
6
ACN
22
2
CAT
50
2
CNX
53
-3
XOM
62
2
IRM
44
-5
MTCH
28
-3
EMR
51
3
MPC
47
3
PCAR
33
2
GOOG
63
2
EMC
36
-6
DNB
60
-2
PPL
72
-3
LB
66
-3
CTAS
37
-2
CI
66
-3
RIG
23
-3
PNR
54
3
LUV
59
-3
XYL
39
6
ACN
22
2
CAT
50
2
CNX
53
-3
XOM
62
2
IRM
44
-5
MTCH
28
-3
EMR
51
3
MPC
47
3
PCAR
33
2
GOOG
63
2
EMC
36
-6
DNB
60
-2
PPL
72
-3
LB
66
-3
CTAS
37
-2
CI
66
-3
RIG
23
-3
PNR
54
3
Financhill
Back

Cara Therapeutics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

CARA
Cara Therapeutics

Last Price:
$5.50
Seasonality Move:
-6.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CARA is experiencing selling pressure, which indicates risk of future bearish movement.

Cara Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.32 Buy
20-day SMA: 5.04 Buy
50-day SMA: 5.01 Buy
200-day SMA: 4.23 Buy
8-day EMA: 5.34 Buy
20-day EMA: 5.17 Buy
50-day EMA: 4.95 Buy
200-day EMA: 6.37 Sell

Cara Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 58.21 Buy
Chaikin Money Flow: -4178 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.76 - 5.32) Buy
Bollinger Bands (100): (3.68 - 5.28) Buy

Cara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cara Therapeutics Stock

Is Cara Therapeutics Stock a Buy?

  • Cara Therapeutics share price is 5.42 while CARA 8-day simple moving average is 5.32, which is a Buy signal.
  • The stock price of CARA is 5.42 while Cara Therapeutics 20-day SMA is 5.04, which makes it a Buy.
  • Cara Therapeutics 50-day simple moving average is 5.01 while CARA share price is 5.42, making it a Buy technically.
  • CARA stock price is 5.42 and Cara Therapeutics 200-day simple moving average is 4.23, creating a Buy signal.

CARA Technical Analysis vs Fundamental Analysis

Sell
38
Cara Therapeutics (CARA) is a Sell

Is Cara Therapeutics a Buy or a Sell?

  • Cara Therapeutics stock is rated a Sell
    The current Cara Therapeutics [CARA] share price is $5.42. The Score for CARA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.

Cara Therapeutics Stock Info

Market Cap:
24.8M
Price in USD:
5.42
Share Volume:
4.2K

Cara Therapeutics 52-Week Range

52-Week High:
11.52
52-Week Low:
2.71
Sell
38
Cara Therapeutics (CARA) is a Sell

Cara Therapeutics Share Price Forecast

Is Cara Therapeutics Stock a Buy?

  • Cara Therapeutics share price is 5.42 while CARA 8-day exponential moving average is 5.34, which is a Buy signal.
  • The stock price of CARA is 5.42 while Cara Therapeutics 20-day EMA is 5.17, which makes it a Buy.
  • Cara Therapeutics 50-day exponential moving average is 4.95 while CARA share price is 5.42, making it a Buy technically.
  • CARA stock price is 5.42 and Cara Therapeutics 200-day simple moving average is 6.37, creating a Sell signal.

Fundamental Analysis of Cara Therapeutics

Is Cara Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Cara Therapeutics

Should I short Cara Therapeutics stock?

* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.